mirtazapine has been researched along with Aggression in 5 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Aggression: Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.
Excerpt | Relevance | Reference |
---|---|---|
"A 23-year-old man with a history of alcohol dependence was admitted to our hospital after self-intoxication with 2700 mg baclofen and 330 mg mirtazapine." | 5.43 | [Aggression and restlessness following baclofen overdose: the narrow line between intoxication and withdrawal symptoms]. ( de Witte, LD; Dekker, D; Kaasjager, K; Kromkamp, M; Veraart, J; Vinkers, CH, 2016) |
"The aim of this study was to conduct a naturalistic, open-label examination of the efficacy and tolerability of mirtazapine (a medication with both serotonergic and noradrenergic properties) in the treatment of associated symptoms of autism and other pervasive developmental disorders (PDDs)." | 5.09 | A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders. ( Guenin, KD; Kohn, AE; McDougle, CJ; Posey, DJ; Swiezy, NB, 2001) |
"A 23-year-old man with a history of alcohol dependence was admitted to our hospital after self-intoxication with 2700 mg baclofen and 330 mg mirtazapine." | 1.43 | [Aggression and restlessness following baclofen overdose: the narrow line between intoxication and withdrawal symptoms]. ( de Witte, LD; Dekker, D; Kaasjager, K; Kromkamp, M; Veraart, J; Vinkers, CH, 2016) |
"Mirtazapine (MIR) is an antidepressant which enhances noradrenergic and serotonergic 5-HT1A neurotransmission via antagomism of central alpha2-adrenergic autoreceptors and heteroreceptors." | 1.31 | Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors. ( Dlaboga, D; Dziedzicka-Wasylewska, M; Maj, J; Rogoz, Z; Wrobel, A, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akbas, B | 1 |
Akca, OF | 1 |
de Witte, LD | 1 |
Dekker, D | 1 |
Veraart, J | 1 |
Kromkamp, M | 1 |
Kaasjager, K | 1 |
Vinkers, CH | 1 |
Nickolson, VJ | 1 |
Wieringa, JH | 1 |
van Delft, AM | 1 |
Posey, DJ | 1 |
Guenin, KD | 1 |
Kohn, AE | 1 |
Swiezy, NB | 1 |
McDougle, CJ | 1 |
Rogoz, Z | 1 |
Wrobel, A | 1 |
Dlaboga, D | 1 |
Maj, J | 1 |
Dziedzicka-Wasylewska, M | 1 |
1 trial available for mirtazapine and Aggression
Article | Year |
---|---|
A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.
Topics: Adolescent; Adult; Aggression; Antidepressive Agents, Tricyclic; Anxiety Disorders; Appetite; Autist | 2001 |
4 other studies available for mirtazapine and Aggression
Article | Year |
---|---|
Treatment of a Child with Autism Spectrum Disorder and Food Refusal Due to Restricted and Repetitive Behaviors.
Topics: Aggression; Aripiprazole; Autism Spectrum Disorder; Child; Feeding and Eating Disorders; Humans; Mal | 2018 |
[Aggression and restlessness following baclofen overdose: the narrow line between intoxication and withdrawal symptoms].
Topics: Adult; Aggression; Alcoholism; Baclofen; Delirium; Drug Overdose; GABA-B Receptor Agonists; Humans; | 2016 |
Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.
Topics: Absorption; Aggression; Animals; Behavior, Animal; Brain; Cell Membrane; Clonidine; Dibenzazepines; | 1982 |
Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aggression; Animals; Antidepressive Agents, | 2002 |